Oral Cefadroxil or Cephalexin (Keflex) is Preferred Over IV Ceftriaxone for Non-Purulent Cellulitis
For adults with non-purulent cellulitis without systemic toxicity, oral cephalexin or cefadroxil should be used as first-line therapy rather than IV ceftriaxone, with hospitalization and IV therapy reserved only for patients with systemic inflammatory response syndrome (SIRS), altered mental status, hemodynamic instability, or failed outpatient treatment. 1
Treatment Algorithm Based on Severity
Mild Non-Purulent Cellulitis (Outpatient)
- No SIRS, normal mental status, hemodynamically stable
- Use oral beta-lactam monotherapy 1
- MRSA coverage is typically unnecessary unless specific risk factors present 1
Moderate to Severe Non-Purulent Cellulitis
- SIRS present, altered mental status, or hemodynamic instability
- Hospitalization required 1
- Consider IV therapy initially, but oral step-down is appropriate once stable
Recommended Dosing Regimens
Cephalexin (Keflex)
- Standard dose: 500 mg every 12 hours for skin and soft tissue infections 2
- Alternative: 250 mg every 6 hours
- High-dose option: 1000 mg four times daily may reduce treatment failure (12.9% vs 3.2%) but causes more minor adverse effects 3
- Duration: 5 days if clinical improvement achieved 1
Cefadroxil
- 1 gram daily as single dose or divided twice daily for skin infections 4
- Once-daily dosing therapeutically equivalent to cephalexin four times daily 5
- Duration: 5 days if clinical improvement achieved 1
Ceftriaxone (When IV Therapy Needed)
- 1-2 grams once daily for skin and soft tissue infections 6
- Reserved for hospitalized patients or severe infections 1
- Can transition to oral therapy once stable
Key Evidence Supporting Oral Over IV Therapy
The IDSA guidelines explicitly state that outpatient therapy is recommended for patients without SIRS, altered mental status, or hemodynamic instability 1. This is critical because:
- Beta-lactams (cefazolin/oxacillin) were successful in 96% of cellulitis cases, demonstrating MRSA is uncommon in typical cellulitis 1
- A 5-day course is as effective as 10 days if clinical improvement occurs 1
- Cephalexin alone was equally efficacious as combination therapy with SMX-TMP for pure cellulitis 1
When to Use IV Ceftriaxone Instead
Hospitalization and IV therapy are indicated when:
- SIRS present (temperature >38°C or <36°C, heart rate >90, respiratory rate >20, WBC >12,000 or <4,000)
- Altered mental status
- Hemodynamic instability
- Concern for deeper or necrotizing infection
- Severely immunocompromised patient
- Poor adherence anticipated
- Outpatient treatment failing 1
Common Pitfalls to Avoid
Over-treating with IV antibiotics: Most non-purulent cellulitis can be managed outpatient with oral agents 1
Unnecessary MRSA coverage: Unless penetrating trauma, injection drug use, purulent drainage, or known MRSA colonization/infection present, beta-lactam monotherapy is appropriate 1
Prolonged antibiotic courses: 5 days is sufficient if improvement occurs; extending beyond this without clear indication increases adverse effects without benefit 1
Ignoring predisposing factors: Examine interdigital toe spaces for tinea pedis, treat edema and venous insufficiency to prevent recurrence 1
Adjunctive Measures
- Elevate affected extremity to promote drainage 1
- Treat predisposing conditions: tinea pedis, edema, venous insufficiency 1
- Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adults 1
Pharmacokinetic Considerations
Recent PK/PD data suggest higher doses of first-generation cephalosporins optimize target attainment, especially for moderate-severe infections caused by S. aureus 7. The pilot trial showing reduced treatment failure with high-dose cephalexin (1000 mg QID) supports this approach, though minor adverse effects increase 3.